Top Analyst Reports for AbbVie, Lockheed Martin & Dell
Today's Research Daily features new research reports on 12 major stocks, including AbbVie Inc. (ABBV), Lockheed Martin ...
REGENXBIO Inc. (NASDAQ:RGNX) Q4 2024 Earnings Call Transcript
Q4 2024 Earnings Call Transcript March 13, 2025 REGENXBIO Inc. beats earnings expectations. Reported EPS is $-1.01, ...
Analysts Remain Bullish on Caribou Biosciences (CRBU) Despite Ongoing Slump in its Shares
Caribou Biosciences (CRBU) reported better-than-expected earnings in the first quarter, with top and bottom-line beats.
Our Top 10 Dividend High Growth Stocks - March 2025
We use our proprietary models to rate stocks quantitatively and qualitatively. Read here for an analysis of our top picks in ...
Buy the companies in this S&P index during these 'turbulent times'
Launched in May 2005, the S&P 500 Dividend Aristocrats index tracks S&P 500 companies that have increased dividends every ...
ELAHERE® (mirvetuximab soravtansine-gynx) Shows Consistent Survival Benefit in Long-Term Analysis for Certain Ovarian Cancer Patients
AbbVie (NYSE: ABBV) today announced the final analysis of the confirmatory Phase 3 MIRASOL trial evaluating the efficacy and safety of ELAHERE® (mirvetuximab soravtansine-gynx) in women with folate ...